Freeport-McMoran Copper & Gold Inc (FCX)vsVersamet Royalties Corporation Common Stock (VMET)
FCX
Freeport-McMoran Copper & Gold Inc
$69.62
+2.11%
BASIC MATERIALS · Cap: $91.20B
VMET
Versamet Royalties Corporation Common Stock
$10.25
+5.13%
BASIC MATERIALS · Cap: $933.87M
Smart Verdict
WallStSmart Research — data-driven comparison
Freeport-McMoran Copper & Gold Inc generates 46699% more annual revenue ($25.87B vs $55.27M). VMET leads profitability with a 58.4% profit margin vs 11.4%. VMET trades at a lower P/E of 28.7x. VMET earns a higher WallStSmart Score of 60/100 (C+).
FCX
Buy58
out of 100
Grade: C
VMET
Buy60
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-71.4%
Fair Value
$40.49
Current Price
$69.62
$29.13 premium
Intrinsic value data unavailable for VMET.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 33.4%
Large-cap with strong market position
Earnings expanding 27.1% YoY
Generating 1.1B in free cash flow
Keeps 58 of every $100 in revenue as profit
Strong operational efficiency at 90.6%
Revenue surging 594.0% year-over-year
Earnings expanding 573.0% YoY
Conservative balance sheet, low leverage
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
Distress zone — elevated risk
Weak financial health signals
Expensive relative to growth rate
Moderate valuation
Smaller company, higher risk/reward
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : FCX
The strongest argument for FCX centers on Operating Margin, Market Cap, EPS Growth.
Bull Case : VMET
The strongest argument for VMET centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 58.4% and operating margin at 90.6%. Revenue growth of 594.0% demonstrates continued momentum.
Bear Case : FCX
The primary concerns for FCX are P/E Ratio, Altman Z-Score, Piotroski F-Score.
Bear Case : VMET
The primary concerns for VMET are P/E Ratio, Market Cap, Altman Z-Score.
Key Dynamics to Monitor
FCX profiles as a declining stock while VMET is a growth play — different risk/reward profiles.
VMET is growing revenue faster at 594.0% — sustainability is the question.
FCX generates stronger free cash flow (1.1B), providing more financial flexibility.
Monitor COPPER industry trends, competitive dynamics, and regulatory changes.
Bottom Line
VMET scores higher overall (60/100 vs 58/100), backed by strong 58.4% margins and 594.0% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Freeport-McMoran Copper & Gold Inc
BASIC MATERIALS · COPPER · USA
Freeport-McMoRan Inc., often called Freeport, is an American mining company based in the Freeport-McMoRan Center, in Phoenix, Arizona.
Visit Website →Versamet Royalties Corporation Common Stock
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Viamet Pharmaceuticals Corp (VMET) is an innovative biopharmaceutical company dedicated to the development of advanced therapeutics targeting serious diseases, particularly in the areas of fungal infections and oncology, utilizing its proprietary metalloenzyme-based technology platform. With a robust and diversified clinical pipeline supported by strategic partnerships and a comprehensive intellectual property portfolio, Viamet is strategically positioned for significant growth. The company remains focused on addressing critical unmet medical needs and is committed to enhancing shareholder value through continued therapeutic advancements in its specialized areas.
Compare with Other COPPER Stocks
Want to dig deeper into these stocks?